{
  "actions": [
    {
      "acted_at": "2005-10-19", 
      "references": [
        {
          "reference": "CR S11567", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2005-10-19", 
      "committee": "Committee on Finance", 
      "references": [
        {
          "reference": "CR S11567-11568", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1893-109", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "109", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2005-10-19", 
  "number": "1893", 
  "official_title": "A bill to permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforwards and certain built-in losses, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4082-109", 
      "reason": "identical"
    }
  ], 
  "short_title": "Biotechnology Future Investment Expansion Act of 2005", 
  "sponsor": {
    "district": null, 
    "name": "Santorum, Rick", 
    "state": "PA", 
    "thomas_id": "01015", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2005-10-19", 
  "subjects": [
    "Accounting", 
    "Biotechnology", 
    "Capital gains tax", 
    "Clinical trials", 
    "Commerce", 
    "Corporate debt", 
    "Corporate finance", 
    "Corporate mergers", 
    "Corporate reorganizations", 
    "Corporation taxes", 
    "Drug industry", 
    "Finance and financial sector", 
    "Health", 
    "Income tax", 
    "Investments", 
    "Losses", 
    "Pharmaceutical research", 
    "Science, technology, communications", 
    "Tax credits", 
    "Tax exclusion", 
    "Tax incentives", 
    "Taxation"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2005-10-19", 
    "text": "Biotechnology Future Investment Expansion Act of 2005 - Amends the Internal Revenue Code to permit certain biomedical research corporations to engage in investments and other transactions involving shifts in ownership without incurring limitations on net operating loss carryforwards and certain built-in losses."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Biotechnology Future Investment Expansion Act of 2005", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforwards and certain built-in losses, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:37:50-05:00"
}